Chat with our sales team
Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells


Pharma CI Conference and Exhibition Title: Pharma CI Conference and Exhibition
PermaLink: http://www.biotech-weblog.com/50226711/pharma_ci_conference_and_exhibition.php

Filed in archive Corporate and Industrial News , Meetings and Other Events by ruth on April 20, 2008

What: Pharma CI Conference and Exhibition When: September 15-17, 2008 Where: Sheraton at Woodbridge Place Hotel in Iselin, New Jersey * The Pharma CI Conference is widely attended by a large variety...

Read the full post.

Advertisement - Book yours here.



Profitability of Transgenic Cotton Title: Profitability of Transgenic Cotton
PermaLink: http://www.biotech-weblog.com/50226711/profitability_of_transgenic_cotton.php

Filed in archive Corporate and Industrial News , Food and Agriculture , Genomics, Proteomics and Bioinformatics by ruth on February 19, 2008

A paper published in the January-February 2008 issue of Agronomy Journal explores the profitability of transgenic cotton cultivars with pest-managing traits. Field experiments were conducted to...

Read the full post.



National Awareness Campaign Surrounding Follow-On Biologics Title: National Awareness Campaign Surrounding Follow-On Biologics
PermaLink: http://www.biotech-weblog.com/50226711/national_awareness_campaign_surrounding_followon_biologics.php

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on February 11, 2008

Richmond-based Insmed, Inc has just launched a broad follow-on biologics education campaign. Part of the innovative campaign is the launch of a YouTube video on Friday to encourage an on-line...

Read the full post.



Roche Invests $387 million in Biotech Drug Research Title: Roche Invests $387 million in Biotech Drug Research
PermaLink: http://www.biotech-weblog.com/50226711/roche_invests_387_million_in_biotech_drug_research.php

Filed in archive Corporate and Industrial News by ruth on January 28, 2008

Roche has announced that it will invest around $430 million Swiss francs ($387 million) in biotech drug research in its production sites Switzerland and Germany. Around 280 million Swiss francs will...

Read the full post.



2008 Asia Pacific Biotechnology Venture Capital Directory Title: 2008 Asia Pacific Biotechnology Venture Capital Directory
PermaLink: http://www.biotech-weblog.com/50226711/2008_asia_pacific_biotechnology_venture_capital_directory.php

Filed in archive Corporate and Industrial News by ruth on January 04, 2008

BioWorld Today has released the 2008 Asia Pacific Biotechnology VC Directory which lists more than 100 VC firms that funds biomedical research in China, India, Korea, Australia, New Zealand and nine...

Read the full post.



Global Institute for Bio-Exploration (GIBEX) Title: Global Institute for Bio-Exploration (GIBEX)
PermaLink: http://www.biotech-weblog.com/50226711/global_institute_for_bioexploration_gibex.php

Filed in archive Corporate and Industrial News , Food and Agriculture , Patents and Intellectual Property Rights by ruth on December 12, 2007

The Global Institute for Bio-Exploration, GIBEX, a joint initiative of the University of Illinois and Rutgers University, The Global Institute for Bio-Exploration, a joint initiative of the...

Read the full post.



Sanofi-Aventis Acquires 19% of Regeneron Title: Sanofi-Aventis Acquires 19% of Regeneron
PermaLink: http://www.biotech-weblog.com/50226711/sanofiaventis_acquires_19_of_regeneron.php

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on November 30, 2007

Sanofi-Aventis is purchasing additional 12 million shares on biotech firm Regeneron for $400 million, upping its shares from 4% to 19%. As part of the new deal, Sanofi and Regeneron plan to bring two...

Read the full post.



Biotech Still Attract VC Investors Title: Biotech Still Attract VC Investors
PermaLink: http://www.biotech-weblog.com/50226711/biotech_still_attract_vc_investors.php

Filed in archive Corporate and Industrial News by ruth on November 30, 2007

According to the National Venture Capital Association, venture capital investing in the biotechnology arena continue to be robust. Biotechnology had $1.1 billion going into 99 deals in the third...

Read the full post.



Heart Drug Trasylol May Boost Risk of Death Title: Heart Drug Trasylol May Boost Risk of Death
PermaLink: http://www.biotech-weblog.com/50226711/heart_drug_trasylol_may_boost_risk_of_death.php

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on October 30, 2007

Foolowing the results of the a study on the efficacy and safety of Trasylol, a drug used to prevent excessive bleeding during heart bypass surgery, the FDA issued a warning that the drug also raises...

Read the full post.



GlaxoSmithKline, AstraZeneca and Roche Form Stem Cell Consortium Title: GlaxoSmithKline, AstraZeneca and Roche Form Stem Cell Consortium
PermaLink: http://www.biotech-weblog.com/50226711/glaxosmithkline_astrazeneca_and_roche_form_stem_cell_consortium.php

Filed in archive Corporate and Industrial News , Stem Cells by ruth on October 03, 2007

Three of the biggest European pharmaceutical companies -GlaxoSmithKline, AstraZeneca and Roche- have launched the Stem Cells for Safer Medicines, or SC4SM, a collaboration to develop stem cells for...

Read the full post.



BIO Investor Forum 2007 Title: BIO Investor Forum 2007
PermaLink: http://www.biotech-weblog.com/50226711/bio_investor_forum_2007.php

Filed in archive Corporate and Industrial News , Meetings and Other Events by ruth on September 07, 2007

What: BIO Investor Forum 2007 When: October 9-11, 2007 Where: Palace Hotel, San Francisco The BIO Investor Forum 2007 showcases leading public and private biotechnology companies, from small to...

Read the full post.



Genetically Engineered Mice Produce Human Live Cells Title: Genetically Engineered Mice Produce Human Live Cells
PermaLink: http://www.biotech-weblog.com/50226711/genetically_engineered_mice_produce_human_live_cells.php

Filed in archive Corporate and Industrial News , Diagnostics, Methodologies and Instrumentation , Genomics, Proteomics and Bioinformatics , Patents and Intellectual Property Rights by ruth on August 13, 2007

Oregon Health & Science University researchers have genetically engineered mice to produce human liver cells which could be used in studies for testing the safety and efficacy of drug lead...

Read the full post.



Biodesign Institute Leads Development of Preventive Cancer Vaccine Title: Biodesign Institute Leads Development of Preventive Cancer Vaccine
PermaLink: http://www.biotech-weblog.com/50226711/biodesign_institute_leads_development_of_preventive_cancer_vaccine.php

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on July 26, 2007

Almost $9M in grants has been received by Biodesign Institute for the development of a preventive vaccine against cancer. Stephen Albert Johnston, PhD, director of the institute's Center for...

Read the full post.



Nestle Took-over Novartis Medical Nutrition for US$2.5bn Title: Nestle Took-over Novartis Medical Nutrition for US$2.5bn
PermaLink: http://www.biotech-weblog.com/50226711/nestle_tookover_novartis_medical_nutrition_for_us25bn.php

Filed in archive Corporate and Industrial News by ruth on July 05, 2007

After a long-awaited deal, Nestle has confirmed its successful take-over of Novartis Medical Nutrition to the tune of US$2.5bn. Not only will the deal strengthen Nestle's health and nutrition...

Read the full post.



NIH Awards Almost $21 M in High-End Instrumentation Title: NIH Awards Almost $21 M in High-End Instrumentation
PermaLink: http://www.biotech-weblog.com/50226711/nih_awards_almost_21_m_in_highend_instrumentation.php

Filed in archive Corporate and Industrial News , Diagnostics, Methodologies and Instrumentation by ruth on June 13, 2007

The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH) will grant a total of $20.65 million to research institutions around the country in 14 High-End...

Read the full post.



WAshington University Invests $55M on International Center for Advanced Renewable Energy and Sustainability (I-CARES) Title: WAshington University Invests $55M on International Center for Advanced Renewable Energy and Sustainability (I-CARES)
PermaLink: http://www.biotech-weblog.com/50226711/washington_university_invests_55m_on_international_center_for_advanced_renewable_energy_and_sustainability_icares.php

Filed in archive Corporate and Industrial News , Energy, Environment and Ecology by ruth on June 07, 2007

The International Center for Advanced Renewable Energy and Sustainability (I-CARES) has been spearheaded by the Washington University in St. Louis to encourage and coordinate university-wide and...

Read the full post.



Amgen Buys Ilypsa for $420 Million Title: Amgen Buys Ilypsa for $420 Million
PermaLink: http://www.biotech-weblog.com/50226711/amgen_buys_ilypsa_for_420_million.php

Filed in archive Corporate and Industrial News by ruth on June 06, 2007

Biotech giant Amgen, Inc has agreed to buy Ilypsa, a privately-held, Sand Francisco based firm focusing on the development of drugs against kidney disease, for $420 million. Ilypsa's lead drug...

Read the full post.



Google Invests $39M in Biotech Start-up on Personal Genetics Title: Google Invests $39M in Biotech Start-up on Personal Genetics
PermaLink: http://www.biotech-weblog.com/50226711/google_invests_39m_in_biotech_startup_on_personal_genetics.php

Filed in archive Corporate and Industrial News , Genomics, Proteomics and Bioinformatics by ruth on May 24, 2007

Google has invested $39 million in 23andme, a privately held, early-stage personal genetics company co-founded by Anne Wojcicki, who is married to Google, Inc. co-founder Sergey Brin. From the 23andme...

Read the full post.



Novartis Acquires Rights to Cytos' Smoking Vaccine Title: Novartis Acquires Rights to Cytos' Smoking Vaccine
PermaLink: http://www.biotech-weblog.com/50226711/novartis_acquires_rights_to_cytos_smoking_vaccine.php

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on April 26, 2007

Novartis AG has acquired worldwide exclusive rights to a novel vaccine candidate against nicotine addiction from Cytos Biotechnology AG for up to 600 million Swiss francs (US$500 million; €366...

Read the full post.



CW ToolbarInstall
RSSrss   | See all blog subscribe options
Googlegoogle   |   What is RSS?
Yahoo!yahoo
AddthisAddThis Feed Button
BloglinesBloglines
Newsletter
Advertisement - Book yours here.

Use our search feature to look for other interesting posts

Just this blog Whole network
Apple iTunes
Advertisement -
Book yours here..


 
  • Would you like to have a new interactive marketing channel for your company? Learn more about Sponsored Blogs with Creative Weblogging. See how we helped companies like Weblin and cellity reach their goals.
  • Would you like to reach millions of blog readers every day? See you banner on hundreds of blogs with TierOneAds? Stay in control measuring conversion in real time. Register now.
  • Would you like to make more money blogging? Use TierOneAds a new platform that allows you as a blogger to set your prices per impression. Register now.
  • Do you have a blog with more than 50k page views from the US? Let us market your blog and earn great fix payments and bonuses.
  • Would you like to see your text link here? Let us know!
Advertisement
Book yours here.



  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'
  • Other blogs in the same channel in the Creative Weblogging Network

Advertisement -
Book yours here..






Advertisement - Book yours here..
 
Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology